304 related articles for article (PubMed ID: 26275479)
41. Rubella-vaccinated students. Follow-up in a public school system.
Schiff GM; Rauh JL; Young B; Trimble S; Rotte T; Schiff BE
JAMA; 1978 Dec; 240(24):2635-7. PubMed ID: 712979
[TBL] [Abstract][Full Text] [Related]
42. Studies on live rubella vaccine. VI. Seroepidemiological surveillance and immunization of adolescents in high school.
Minekawa Y; Takahashi M; Ueda S; Ogino T
Biken J; 1975 Sep; 18(3):149-54. PubMed ID: 1191245
[TBL] [Abstract][Full Text] [Related]
43. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection.
Horstmann DM; Schluederberg A; Emmons JE; Evans BK; Randolph MF; Andiman WA
Rev Infect Dis; 1985; 7 Suppl 1():S80-5. PubMed ID: 4001740
[TBL] [Abstract][Full Text] [Related]
44. Determination of rubella virus-specific humoral and cell-mediated immunity in pregnant women with negative or equivocal rubella-specific IgG in routine screening.
Picone O; Bouthry E; Bejaoui-Olhmann Y; Cordier AG; Nedellec S; Letourneau A; Carbonel M; Brollo M; Grangeot-Keros L; Ayoubi JM; Benachi A; Rouge E; Vauloup-Fellous C
J Clin Virol; 2019 Mar; 112():27-33. PubMed ID: 30711798
[TBL] [Abstract][Full Text] [Related]
45. Further evaluation of the optimum age for rubella vaccine administration.
Wilkins J; Wehrle PF
Am J Dis Child; 1979 Dec; 133(12):1237-9. PubMed ID: 517472
[TBL] [Abstract][Full Text] [Related]
46. [What EIA assay levels correspond to rubella antibody HI assay titer?].
Terada K; Inoue M; Wakabayashi T; Ogita S; Ouchi K
Kansenshogaku Zasshi; 2009 Jan; 83(1):26-30. PubMed ID: 19227221
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination.
Lambert ND; Haralambieva IH; Kennedy RB; Ovsyannikova IG; Pankratz VS; Poland GA
J Infect Dis; 2015 Mar; 211(6):898-905. PubMed ID: 25293367
[TBL] [Abstract][Full Text] [Related]
48. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
Waldman RH; Ganguly R
Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
[TBL] [Abstract][Full Text] [Related]
49. A study of rubella immunity and resistance to infection.
Davis WJ; Larson HE; Simsarian JP; Parkman PD; Meyer HM
JAMA; 1971 Jan; 215(4):600-8. PubMed ID: 5107436
[No Abstract] [Full Text] [Related]
50. [Safety and efficacy in two-dose vaccination using measles and rubella combined (MR) vaccine].
Terada K; Ouchi K; Ihara T; Okada K; Numazaki K
Kansenshogaku Zasshi; 2008 Sep; 82(5):414-8. PubMed ID: 18975583
[TBL] [Abstract][Full Text] [Related]
51. [Prepuberal rubella vaccination and development of antibodytiters during five years (author's transl)].
Müller G; Baumann H
Padiatr Padol; 1978; 13(3):291-7. PubMed ID: 673433
[TBL] [Abstract][Full Text] [Related]
52. Humoral immune response after primary rubella virus infection and after vaccination.
Vauloup-Fellous C; Grangeot-Keros L
Clin Vaccine Immunol; 2007 May; 14(5):644-7. PubMed ID: 17344342
[TBL] [Abstract][Full Text] [Related]
53. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
Grillner L
J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
[TBL] [Abstract][Full Text] [Related]
54. Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures.
Vesikari T; Kanra GY; Buimovici-Klein E; Cooper LZ
Clin Exp Immunol; 1975 Jan; 19(1):33-43. PubMed ID: 1081925
[TBL] [Abstract][Full Text] [Related]
55. [Avidity of immunoglobulin G to rubella virus in post-vaccination and post-infection immunity].
Desiatskova RG; Zargar'iants AI; Stepanov AV; Zverev VV
Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):6-11. PubMed ID: 17882830
[TBL] [Abstract][Full Text] [Related]
56. Testing for rubella-specific IgG antibody in urine.
Terada K; Niizuma T; Kataoka N; Niitani Y
Pediatr Infect Dis J; 2000 Feb; 19(2):104-8. PubMed ID: 10693994
[TBL] [Abstract][Full Text] [Related]
57. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women.
Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R
East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431
[TBL] [Abstract][Full Text] [Related]
58. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination.
Ovsyannikova IG; Jacobson RM; Vierkant RA; Jacobsen SJ; Pankratz VS; Poland GA
Hum Immunol; 2004 Dec; 65(12):1506-15. PubMed ID: 15603879
[TBL] [Abstract][Full Text] [Related]
59. The immunoglobulin M response to rubella vaccine in young adult women.
Mortimer PP; Edwards JM; Porter AD; Tedder RS; Haslehurst J
J Hyg (Lond); 1984 Jun; 92(3):277-83. PubMed ID: 6376624
[TBL] [Abstract][Full Text] [Related]
60. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
